empower the Executive Committee or the Managing Director to amend or change the date of determination of shareholders who shall be entitled to attend the Extraordinary General Meeting of Shareholders No1
under Section 225 of the Securities and Exchange Act B.E. 2535 (as amended), and to empower the Executive Committee or the Managing Director to amend or change the date of determination of shareholders
approved person has not complied with the rules under sub clause (4/1): (a) wholly or partly cease the advertisement or sale promotion; (b) amend the information or the statement in the advertisement or sale
duties and rules on conflicts of interest for directors, and introducing characteristics that would make an individual unfit to be a director. Shareholder’s rights to amend the meeting agenda, approve
none of the Company, nor any of its agents, employees or advisors intends or has any duty or obligation to supplement, amend, update or revise any such forward-looking statements to reflect any change in
agreement, decide, amend the details or conditions, and take any necessary and proper actions for the benefits of the Company including, but not limited to, signing of agreement, memorandum, or other
into agreement, decide, amend the details or conditions, and take any necessary and proper actions for the benefits of the Company including, but not limited to, signing of agreement, memorandum, or
authorization of the Chief Executive Officer: (1) to enter into negotiations, agreement, to determine, change, amend any detail, condition, and procedure necessary for the acquisition of ordinary shares, the VTO
statements speak only as at the date of this presentation, and the Company does not undertake any duty or obligation to supplement, amend, update or revise any such statements. The Company does not make any